Literature DB >> 19952296

Fragility fractures in chronic kidney disease: an opinion-based approach.

Paul D Miller1.   

Abstract

When a patient with chronic kidney disease suffers a fragility fracture, a key question is whether the patient has osteoporosis or, instead, renal osteodystrophy. Bone densitometry does not help in this distinction: biochemical tests, and sometimes also bone biopsy, are needed. However, even if the patient has osteoporosis, we have little evidence to guide our treatment decisions in cases of advanced chronic kidney disease.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19952296     DOI： 10.3949/ccjm.76a.08108

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


  10 in total

1.  A review of the efficacy and safety of denosumab in postmenopausal women with osteoporosis.

Authors:  Paul D Miller
Journal:  Ther Adv Musculoskelet Dis       Date:  2011-12       Impact factor: 5.346

Review 2.  Fracture risk assessment in patients with chronic kidney disease.

Authors:  S A Jamal; S L West; P D Miller
Journal:  Osteoporos Int       Date:  2011-09-08       Impact factor: 4.507

Review 3.  Chronic kidney disease and osteoporosis: evaluation and management.

Authors:  Paul D Miller
Journal:  Bonekey Rep       Date:  2014-06-25

4.  Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study.

Authors:  Danielle E Robinson; M Sanni Ali; Victoria Y Strauss; Leena Elhussein; Bo Abrahamsen; Nigel K Arden; Yoav Ben-Shlomo; Fergus Caskey; Cyrus Cooper; Daniel Dedman; Antonella Delmestri; Andrew Judge; Muhammad Kassim Javaid; Daniel Prieto-Alhambra
Journal:  Health Technol Assess       Date:  2021-03       Impact factor: 4.014

Review 5.  Chronic kidney disease and the skeleton.

Authors:  Paul D Miller
Journal:  Bone Res       Date:  2014-12-23       Impact factor: 13.567

Review 6.  Bisphophonates in CKD patients with low bone mineral density.

Authors:  Wen-Chih Liu; Jen-Fen Yen; Cheng-Lin Lang; Ming-Tso Yan; Kuo-Cheng Lu
Journal:  ScientificWorldJournal       Date:  2013-12-31

Review 7.  Challenges in implementing and maintaining osteoporosis therapy.

Authors:  Ankita Modi; Shiva Sajjan; Sampada Gandhi
Journal:  Int J Womens Health       Date:  2014-08-13

8.  Kidney Function Change and All-Cause Mortality in Denosumab Users with and without Chronic Kidney Disease.

Authors:  Ping-Hsun Wu; Ming-Yen Lin; Teng-Hui Huang; Tien-Ching Lee; Sung-Yen Lin; Chung-Hwan Chen; Mei-Chuan Kuo; Yi-Wen Chiu; Jer-Ming Chang; Shang-Jyh Hwang
Journal:  J Pers Med       Date:  2022-01-31

9.  Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease.

Authors:  Paul D Miller; Jonathan D Adachi; Ben-Hur Albergaria; Angela M Cheung; Arkadi A Chines; Evelien Gielen; Bente L Langdahl; Akimitsu Miyauchi; Mary Oates; Ian R Reid; Norma Ruiz Santiago; Mark Vanderkelen; Zhenxun Wang; Zhigang Yu
Journal:  J Bone Miner Res       Date:  2022-05-20       Impact factor: 6.390

10.  Bipolar Hemiarthroplasty and Parathyroidectomy at the Same Setting for Fragility Fractures Secondary to Renal Bone Disease.

Authors:  Amila Silva; Adriel You Wei Tay; Chung Fai Jeremy Ng; Tet Sen Howe
Journal:  Indian J Orthop       Date:  2020-06-03       Impact factor: 1.251
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.